Navigation Links
Covance to Present at Citi 2012 Global Health Care Conference
Date:2/24/2012

PRINCETON, N.J., Feb. 24, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Citi 2012 Global Health Care Conference on Tuesday, February  28, 2012 at 9:00 a.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 11,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release (and in the webcast announced in this press release), which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue, earnings growth, and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage development services, testing mix and geographic mix of kit receipts in central laboratories, fluctuations in currency exchange rates, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.


'/>"/>
SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Covance Board Authorizes $300 Million Stock Buyback
2. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2011 Financial Results Conference Call
3. Covance to Present at Credit Suisse 2011 Healthcare Conference
4. Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
5. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
6. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2011 Financial Results Conference Call
7. Covance to Present at Morgan Stanley Global Healthcare Conference
8. Covance Reports Second Quarter Revenue of $518 Million, GAAP EPS of $0.61, and Pro Forma EPS of $0.66
9. Covance to Present at Bairds 2011 Growth Stock Conference
10. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2011 Financial Results Conference Call
11. Covance to Present at the 2nd Annual Morningstar/NYSSA Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and other ... up healthcare costs and threatening outcomes, were problems taken ... and IVD industry that support them, met this week. ... researcher said that drugs of abuse, procalcitonin and acute ... at the organization,s 69th meeting in San ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Centrifugation is more than just spinning. Like ... we can no longer do without. And just like a car, there are a ... In this webinar, attendees will learn about the most important safety aspects while using ...
(Date:8/16/2017)... Bethpage, NY (PRWEB) , ... August 16, 2017 , ... ... Kullen, Long Island’s original family-owned supermarket, has put together suggestions for enjoying the season ... new recipe or activity, everyone in the family can join in on the fun. ...
(Date:8/16/2017)... and CARTERSVILLE, Georgia (PRWEB) , ... August 16, 2017 , ... ... the fastest growing companies in the U.S. for the second year in a row. ... growth over the past three years. , “To be on the list once is ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... collaborating with a New England student to educate the public on the impact ... 2016 for launching the first-ever National Concussion Awareness Day. , Brooke is working ...
(Date:8/16/2017)... KS (PRWEB) , ... August 16, 2017 , ... ... latest beneficiary of their recently launched community enrichment program. Partnering once again with ... the KC Superstar competition to help find the area’s very own American Idol. ...
Breaking Medicine News(10 mins):